Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Change in Intangibles: 2023-2024

Historic Change in Intangibles for Rhythm Pharmaceuticals (RYTM) over the last 2 years, with Dec 2024 value amounting to $40.5 million.

  • Rhythm Pharmaceuticals' Change in Intangibles rose 83.82% to $500,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $41.6 million, marking a year-over-year change of. This contributed to the annual value of $40.5 million for FY2024, which is 614.66% up from last year.
  • Latest data reveals that Rhythm Pharmaceuticals reported Change in Intangibles of $40.5 million as of FY2024, which was up 614.66% from $5.7 million recorded in FY2023.
  • Over the past 5 years, Rhythm Pharmaceuticals' Change in Intangibles peaked at $40.5 million during FY2024, and registered a low of $5.7 million during FY2023.
  • Moreover, its 2-year median value for Change in Intangibles was $23.1 million (2023), whereas its average is $23.1 million.
  • Data for Rhythm Pharmaceuticals' Change in Intangibles shows a peak YoY spiked of 614.66% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Rhythm Pharmaceuticals' Change in Intangibles stood at $5.7 million in 2023, then spiked by 614.66% to $40.5 million in 2024.